Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Shubhankar K Singh"'
Autor:
Fauzia Jamal, Manish Kumar Singh, Jagadish Hansa, Pushpanjali, Pushkar Shivam, Sarita Kumari, Shyam Narayan, Shubhankar K Singh
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 12, Iss 11, Pp DC22-DC29 (2018)
Introduction: Assenting diagnosis of Visceral Leishmaniasis (VL) relies on the detection of Leishmania donovani (L. donovani) in splenic and bone marrow specimens obtained by invasive techniques. Thus, the development of inexpensive, non-invasive ser
Externí odkaz:
https://doaj.org/article/11b2f693661c4390a60acb47dca162b5
Autor:
Fauzia Jamal, Pushkar Shivam, Sarita Kumari, Manish Kumar Singh, Abul Hasan Sardar, Pushpanjali, Selvasankar Murugesan, Shyam Narayan, Anil Kumar Gupta, Krishna Pandey, V N R Das, Vahab Ali, Sanjiva Bimal, Pradeep Das, Shubhankar K Singh
Publikováno v:
PLoS ONE, Vol 12, Iss 8, p e0182474 (2017)
The unreliability of most of the existing antibody-based diagnostic kits to discriminate between active and treated VL cases, relapse situation and reinfection are a major hurdle in controlling the cases of Kala-azar in an endemic area. An antigen ta
Externí odkaz:
https://doaj.org/article/dd599a09148f4744bcf8665095043388
Autor:
Fauzia Jamal, Manish K. Singh, Jagadish Hansa, Pushpanjali, Ghufran Ahmad, Manas Ranjan Dikhit, Mohd Saad Umar, Sanjiva Bimal, Pradeep Das, Anzar Abdul Mujeeb, Shubhankar K. Singh, Swaleha Zubair, Mohammad Owais
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Externí odkaz:
https://doaj.org/article/f5d317daf66b476b81c57777fabc4a2a
Autor:
Fauzia Jamal, Manish K. Singh, Jagadish Hansa, Pushpanjali, Ghufran Ahmad, Manas Ranjan Dikhit, Mohd Saad Umar, Sanjiva Bimal, Pradeep Das, Anzar Abdul Mujeeb, Shubhankar K. Singh, Swaleha Zubair, Mohammad Owais
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Visceral leishmaniasis (VL)-related mortality and morbidity imposes a great deal of health concern across the globe. The existing anti-leishmanial drug regimen generally fails to eliminate newly emerging resistant isolates of this dreadful parasite.
Externí odkaz:
https://doaj.org/article/57439baa027f40d28028ac05264d1dd8
Publikováno v:
Journal of Biomolecular Structure and Dynamics. 39:6056-6069
The emergence of increased resistance to the available drugs has created a situation that demands to find out more specific molecular drug targets for Leishmaniasis. The enoyl acyl carrier protein ...
Autor:
Shubhankar K. Singh, Vidya Nand Rabi Das, Sanjiva Bimal, Pradeep Das, Niyamat Ali Siddiqui, Sunil Kumar, Chandra Shekhar Lal, Sanjay Kumar Sinha, Roshan Kamal Topno, Krishna Pandey
Publikováno v:
Transactions of The Royal Society of Tropical Medicine and Hygiene. 113:332-340
BACKGROUND Surveillance of post-kala-azar dermal leishmaniasis (PKDL) is critical to the elimination of visceral leishmaniasis (VL). In this study we assessed the feasibility of using trained field workers for detecting suspected PKDL cases. METHODS
Publikováno v:
Journal of Biomolecular Structure and Dynamics. 37:4481-4493
NAD (nicotinamide adenine dinucleotide) synthase catalyses the biochemical synthesis of NAD, from nicotinic acid adenine dinucleotide (NAAD). NAD may be synthesized through the de novo pathways and/or the salvage pathways in cells. However, in Leishm
Publikováno v:
SSRN Electronic Journal.
The quantification of mRNA expression can serve as the infallible bioassay platform in case of the unavailability of a specific antibody to assess a particular biomarker. Here, we have established a conjugate of GNP with a thiolated detection probe a
The analytical quality by design (A-QbD) approach includes the concept of practical use of QbD into the development of analytical methods. Nowadays, because of the robustness of method, the pharmaceutical and biotech companies have shown much conside
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fbee1abf9b531c2564952f741fec5e67
https://doi.org/10.1016/b978-0-12-820332-3.00004-2
https://doi.org/10.1016/b978-0-12-820332-3.00004-2
Autor:
Manish K Singh, Sanjiva Bimal, Mohd Saad Umar, Anzar Abdul Mujeeb, Swaleha Zubair, Ghufran Ahmad, Shubhankar K. Singh, Manas Ranjan Dikhit, Pushpanjali, Pradeep Das, Fauzia Jamal, Mohammad Owais, Jagadish Hansa
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Frontiers in Immunology
Frontiers in Immunology
Visceral leishmaniasis (VL)-related mortality and morbidity imposes a great deal of health concern across the globe. The existing anti-leishmanial drug regimen generally fails to eliminate newly emerging resistant isolates of this dreadful parasite.